<em>In vitro</em> study of new combinations for local antibiotic therapy with calcium sulphate - Near constant release of ceftriaxone offers new treatment options

Wahl, Peter; Rönn, Karolin; Bohner, Marc; Decosterd, Laurent A; Meier, Christoph; Schläppi, Michel; Festa, Sandrine; Gautier, Emanuel

doi:https://doi.org/10.7150/jbji.26218

Articles | Volume 3, issue 4

Article
Metrics
Related articles

Articles | Volume 3, issue 4

https://doi.org/10.7150/jbji.26218

Articles | Volume 3, issue 4

Article
Metrics
Related articles

Original full-length article

04 Oct 2018

Original full-length article |

| 04 Oct 2018

In vitro study of new combinations for local antibiotic therapy with calcium sulphate - Near constant release of ceftriaxone offers new treatment options

Peter Wahl, Karolin Rönn, Marc Bohner, Laurent A Decosterd, Christoph Meier, Michel Schläppi, Sandrine Festa, and Emanuel Gautier

Peter Wahl

Department of Orthopaedic Surgery, HFR Fribourg - Cantonal Hospital, Fribourg, Switzerland;

Division of Orthopaedics and Traumatology, Cantonal Hospital Winterthur, Winterthur, Switzerland;

Karolin Rönn

Department of Orthopaedic Surgery, HFR Fribourg - Cantonal Hospital, Fribourg, Switzerland;

Schulthess Clinic, Zürich, Switzerland;

Marc Bohner

RMS Foundation, Bettlach, Switzerland;

Laurent A Decosterd

Division of Clinical Pharmacology, University Hospital Centre CHUV, Lausanne, Switzerland.

Christoph Meier

Division of Orthopaedics and Traumatology, Cantonal Hospital Winterthur, Winterthur, Switzerland;

Michel Schläppi

Division of Orthopaedics and Traumatology, Cantonal Hospital Winterthur, Winterthur, Switzerland;

Sandrine Festa

Department of Orthopaedic Surgery, HFR Fribourg - Cantonal Hospital, Fribourg, Switzerland;

Emanuel Gautier

Department of Orthopaedic Surgery, HFR Fribourg - Cantonal Hospital, Fribourg, Switzerland;

Cited articles

Henry SL, Galloway KP. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clinical pharmacokinetics. 1995;29:36–45.

McKee MD, Li-Bland EA, Wild LM, Schemitsch EH. A prospective, randomized clinical trial comparing an antibiotic-impregnated bioabsorbable bone substitute with standard antibiotic-impregnated cement beads in the treatment of chronic osteomyelitis and infected nonunion. Journal of orthopaedic trauma. 2010;24:483–90.

Landersdorfer CB, Bulitta JB, Kinzig M, Holzgrabe U, Sorgel F. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clinical pharmacokinetics. 2009;48:89–124.

Iarikov D, Demian H, Rubin D, Alexander J, Nambiar S. Choice and doses of antibacterial agents for cement spacers in treatment of prosthetic joint infections: review of published studies. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2012;55:1474–80.

Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotics in bone infections. Drugs. 2000;59:1223–32.

Hsieh PH, Tai CL, Lee PC, Chang YH. Liquid gentamicin and vancomycin in bone cement: a potentially more cost-effective regimen. The Journal of arthroplasty. 2009;24:125–30.

Chang W, Colangeli M, Colangeli S, Di Bella C, Gozzi E, Donati D. Adult osteomyelitis: debridement versus debridement plus Osteoset T pellets. Acta orthopaedica Belgica. 2007;73:238–43.

Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P. Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Joint Res. 2017;6:296–306. [PMC free article]

Anagnostakos K, Wilmes P, Schmitt E, Kelm J. Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo. Acta orthopaedica. 2009;80:193–7. [PMC free article]

Hsieh PH, Huang KC, Tai CL. Liquid gentamicin in bone cement spacers: in vivo antibiotic release and systemic safety in two-stage revision of infected hip arthroplasty. The Journal of trauma. 2009;66:804–8.

Post V, Wahl P, Richards RG, Moriarty TF. Vancomycin displays time dependent eradication of mature Staphylococcus aureus biofilms. Journal of orthopaedic research: official publication of the Orthopaedic Research Society; 2016.

Wahl P, Guidi M, Benninger E, Ronn K, Gautier E, Buclin T, The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material. Bone Joint J; 2017. p. 99. -B: 1537-44.

Kelly CM, Wilkins RM, Gitelis S, Hartjen C, Watson JT, Kim PT. The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clinical orthopaedics and related research; 2001. pp. 42–50.

Ferguson JY, Dudareva M, Riley ND, Stubbs D, Atkins BL, McNally MA. The use of a biodegradable antibiotic-loaded calcium sulphate carrier containing tobramycin for the treatment of chronic osteomyelitis: a series of 195 cases. Bone Joint J; 2014. p. 96. -B: 829-36.

Helgeson MD, Potter BK, Tucker CJ, Frisch HM, Shawen SB. Antibiotic-impregnated calcium sulfate use in combat-related open fractures. Orthopedics. 2009;32:323.

Wang Y, Wang X, Li H, Xue D, Shi Z, Qi Y. et al. Assessing the character of the rhBMP-2- and vancomycin-loaded calcium sulphate composites in vitro and in vivo. Archives of orthopaedic and trauma surgery. 2011;131:991–1001.

Richelsoph KC, Webb ND, Haggard WO. Elution behavior of daptomycin-loaded calcium sulfate pellets: a preliminary study. Clinical orthopaedics and related research. 2007;461:68–73.

Panagopoulos P, Tsaganos T, Plachouras D, Carrer DP, Papadopoulos A, Giamarellou H. et al. in vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan) International journal of antimicrobial agents. 2008;32:485–7.

Wichelhaus TA, Dingeldein E, Rauschmann M, Kluge S, Dieterich R, Schafer V. et al. Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads. The Journal of antimicrobial chemotherapy. 2001;48:117–9.

Bowyer GW, Cumberland N. Antibiotic release from impregnated pellets and beads. The Journal of trauma. 1994;36:331–5.

Mousset B, Benoit MA, Delloye C, Bouillet R, Gillard J. Biodegradable implants for potential use in bone infection. An in vitro study of antibiotic-loaded calcium sulphate. International orthopaedics. 1995;19:157–61.

Roberts R, McConoughey SJ, Calhoun JH. Size and composition of synthetic calcium sulfate beads influence dissolution and elution rates in vitro. Journal of biomedical materials research Part B, Applied biomaterials. 2014;102:667–73.

Aiken SS, Cooper JJ, Florance H, Robinson MT, Michell S. Local release of antibiotics for surgical site infection management using high-purity calcium sulfate: an in vitro elution study. Surg Infect (Larchmt) 2015;16:54–61. [PMC free article]

Stengel D, Bauwens K, Sehouli J, Ekkernkamp A, Porzsolt F. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. The Lancet Infectious diseases. 2001;1:175–88.

Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM. et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2013;56:e1–e25.

Schafer P, Fink B, Sandow D, Margull A, Berger I, Frommelt L. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008;47:1403–9.

Schwotzer N, Wahl P, Fracheboud D, Gautier E, Chuard C. Optimal culture incubation time in orthopedic device-associated infections: a retrospective analysis of prolonged 14-day incubation. Journal of clinical microbiology. 2014;52:61–6. [PMC free article]

Zuluaga AF, Galvis W, Saldarriaga JG, Agudelo M, Salazar BE, Vesga O. Etiologic diagnosis of chronic osteomyelitis: a prospective study. Archives of internal medicine. 2006;166:95–100.

Palmer SM, Kang SL, Cappelletty DM, Rybak MJ. Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model. Antimicrob Agents Chemother. 1995;39:1764–71. [PMC free article]

Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. Journal of orthopaedic surgery. 2002;10:53–60.

HCI Solutions AG: compendium.ch by HCI Solutions. Web Version 1.0.0.15034. http://www.compendium.ch/

Matuschek E, Brown DF, Kahlmeter G. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20:O255–66.

EUCAST: Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0. http://www.eucast.org/clinical_breakpoints/

DrugBank: Breakpoint tables for interpretation of MICs and zone diameters. Version 5.1.1. http://www.drugbank.ca/

Thomas MV, Puleo DA, Al-Sabbagh M. Calcium sulfate: a review. Journal of long-term effects of medical implants. 2005;15:599–607.

Rauschmann MA, Wichelhaus TA, Stirnal V, Dingeldein E, Zichner L, Schnettler R. et al. Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections. Biomaterials. 2005;26:2677–84.

Kweon C, McLaren AC, Leon C, McLemore R. Amphotericin B delivery from bone cement increases with porosity but strength decreases. Clinical orthopaedics and related research. 2011;469:3002–7. [PMC free article]

Anguita-Alonso P, Rouse MS, Piper KE, Jacofsky DJ, Osmon DR, Patel R. Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clinical orthopaedics and related research. 2006;445:239–44.

Samuel S, Mathew BS, Veeraraghavan B, Fleming DH, Chittaranjan SB, Prakash JA. in vitro study of elution kinetics and bio-activity of meropenem-loaded acrylic bone cement. Journal of Orthopaedics and Traumatology. 2012;13:131–6. [PMC free article]

Bohner M, Lemaitre J, Van Landuyt P, Zambelli PY, Merkle HP, Gander B. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system. J Pharm Sci. 1997;86:565–72.

Zilberman M, Elsner JJ. Antibiotic-eluting medical devices for various applications. Journal of controlled release: official journal of the Controlled Release Society. 2008;130:202–15.

Zander J, Maier B, Zoller M, Dobbeler G, Frey L, Teupser D. et al. Effects of biobanking conditions on six antibiotic substances in human serum assessed by a novel evaluation protocol. Clin Chem Lab Med. 2016;54:265–74.

Esteban MJ, Canton E, Rius F. Influence of temperature on degradation kinetics of ceftriaxone in diluted and undiluted human serum. Antimicrob Agents Chemother. 1990;34:1268–70. [PMC free article]

Mouton JW, Theuretzbacher U, Craig WA, Tulkens PM, Derendorf H, Cars O. Tissue concentrations: do we ever learn? The Journal of antimicrobial chemotherapy. 2008;61:235–7.

Schmutz HR, Detampel P, Buhler T, Buttler A, Gygax B, Huwyler J. in vitro assessment of the formation of ceftriaxone-calcium precipitates in human plasma. J Pharm Sci. 2011;100:2300–10.

Chutipongtanate S, Thongboonkerd V. Ceftriaxone crystallization and its potential role in kidney stone formation. Biochem Biophys Res Commun. 2011;406:396–402.

Shiffman ML, Keith FB, Moore EW. Pathogenesis of ceftriaxone-associated biliary sludge. in vitro studies of calcium-ceftriaxone binding and solubility. Gastroenterology. 1990;99:1772–8.

Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995;22:89–96.

Zeitlinger M, Sauermann R, Fille M, Hausdorfer J, Leitner I, Muller M. Plasma protein binding of fluoroquinolones affects antimicrobial activity. The Journal of antimicrobial chemotherapy. 2008;61:561–7.

Adaway JE, Keevil BG. Therapeutic drug monitoring and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;883-884:33–49.

Bonev B, Hooper J, Parisot J. Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method. The Journal of antimicrobial chemotherapy. 2008;61:1295–301.

Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E. et al. Management of bleeding following major trauma: an updated European guideline. Critical care. 2010;14:R52. [PMC free article]

Srinivas NR. Dodging matrix effects in liquid chromatography tandem mass spectrometric assays-compilation of key learnings and perspectives. Biomed Chromatogr. 2009;23:451–4.

Keevil BG, Lockhart SJ, Cooper DP. Determination of tobramycin in serum using liquid chromatography-tandem mass spectrometry and comparison with a fluorescence polarisation assay. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;794:329–35.

Holtom PD, Pavkovic SA, Bravos PD, Patzakis MJ, Shepherd LE, Frenkel B. Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2000;18:721–7.

Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clinical orthopaedics and related research. 2007;462:200–6.

Rathbone CR, Cross JD, Brown KV, Murray CK, Wenke JC. Effect of various concentrations of antibiotics on osteogenic cell viability and activity. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2011;29:1070–4.

Naal FD, Salzmann GM, von Knoch F, Tuebel J, Diehl P, Gradinger R. et al. The effects of clindamycin on human osteoblasts in vitro. Archives of orthopaedic and trauma surgery. 2008;128:317–23.